Somnomed finds UK distribution partner
Tuesday, 08 July, 2008
Somnomed [ASX: SOM] has appointed Intus Healthcare as the company's distribution partner for the UK market.
Intus will distribute Somnomed's dental Mandibular Advancement Splint (MAS) device for sleep apnea and snoring therapy device to the market.
The UK is generally considered to be one of the most important sleep therapy markets in Europe.
Intus is a major supplier of sleep therapy products, and is headquartered on the outskirts of London.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
